Funds
Deutsche Börse, Citi and Deutsche Bank have led a USD15 million fundraising round in CloudMargin, provider of a collateral and margin management solution native to the cloud.Read the full story at Institutional Asset Manager…
The SS&C GlobeOp Forward Redemption Indicator for September 2020 measured 3.43 per cent, up from 3.08 per cent in August.“SS&C GlobeOp’s Forward Redemption Indicator of 3.43 per cent for September 2020 compares favourably with the 3.67 per cent reported a year ago and September’s long-term averages,” says Bill Stone, Chairman and Chief Executive Officer, SS&C Technologies. “This decrease in redemption notices is consistent with the recent strong trend in hedge fund asset retention, indicating investor confidence remains high.”
The SS&C GlobeOp Forward Redemption Indicator represents the sum of forward redemption notices received from investors in hedge funds administered by SS&C
Tellworth Investments has launched the The Tellworth British Recovery & Growth Trust, which commenced its initial public offering on 16 September 2020. Read the full story at Wealth Adviser…
The Westbeck Volta Fund, a global long/short equity strategy launched last year by London-based energy specialist hedge fund Westbeck Capital to trade the emerging battery revolution, has advanced more than 18 per cent so far in 2020.
Hedge fund short sellers are circling Nikola Corporation, the electric vehicle and component manufacturer at the centre of fraud allegations, with the Nasdaq-listed firm’s share price tipped to tumble this week following executive chairman Trevor Milton’s sudden resignation on Sunday night (20 September).
Hickory Lane Capital Management, a New York-based fundamental equities-focused investment manager, is tapping into opportunities across the TMT, industrials and consumer sectors with a new long/short equity strategy, which has launched with USD100 million in assets anchored by asset management seeder Investcorp-Tages.
Established in July this year by former Brahman Capital managing director and partner Joshua Pearl, Hickory Lane trades technology, media, telecommunications, industrials and consumer stocks on a long and short basis using a mix of long-term fundamental stock selection and top-down sector analyses.
The fund invests in stocks from a balance sheet perspective, with the investment portfolio taking
The frantic hunt for an effective vaccine against coronavirus could leave some pharmaceutical companies highly exposed in a fiercely competitive race – and UK hedge fund Argonaut Capital is weighing in with several key bets against the sector.
ThirdYear Capital, a Munich-based quantitative macro specialist, has paired up with Cologne-based fund initiator Agathon Capital to unveil a new systematic global macro hedge fund strategy which targets opportunities stemming from short-term economic data trends.
The ART Global Macro Fund uses near-term economic forecasts to identify trading opportunities in fundamental financial trends as well as turning points in capital markets.
The fund, which launched last month with EUR20 million (USD23.6 million) in seed capital, trades a range of liquid and exchange-traded instruments including equities, government bond, inflation and currency futures, and can use derivatives to build short positions.
ThirdYear’s absolute
Managed futures funds turned in another positive month in August returning 0.18 per cent, according to the Barclay CTA Index, compiled by BarclayHedge, a division of Backstop Solutions. Year-to-date, CTAs are up 2.73 per cent through August.
“The S&P 500 extended its on-going rally to five months, prices for energy and precious metals rose and the US dollar continued to weaken against most currencies,” says Sol Waksman, president of BarclayHedge. “Other futures markets were not as accommodating as evidenced by an even split on the month between winning and losing funds.”
Sectors making up the Barclay CTA Indices were also evenly
Bloomberg and Goldman Sachs Asset Management (GSAM) have launched a comprehensive suite of 21 alternative risk premia benchmark indices. The Bloomberg GSAM Risk Premia Indices, available through the Bloomberg Terminal, represent fully transparent and replicable indices of widely accepted alternative risk premia styles for liquid, rules-based investment strategies.
These new indices combine Bloomberg’s years of experience in systematic strategies research with the field expertise and research insights from GSAM’s Quantitative Investment Strategies team, as well as valuable feedback from asset owners and consultants. The indices are replicable, transparent and represent investment styles for which there is practitioner consensus, supporting academic
